STING1 and metabolic dysfunction-associated steatotic liver disease: Qiao et al. reported that excessive activation of STING in the liver was associated with the progression of nonalcoholic fatty liver disease through enhancing macrophage-mediated hepatic inflammation and fibrosis [38].